Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-guided MMF in pediatric lupus nephritis
NCT05101447Phase 2Withdrawn
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jul 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mycophenolate mofetil in lupus nephritis (LN), sponsored by Cincinnati Children's Hospital Medical Center. Planned start Jul 2023; status: withdrawn.
02
Drugs
mycophenolate mofetil
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT05101447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05101447.